Home › Funds › Ullmann Wealth Partners Group, LLC › JNJ

Ullmann Wealth Partners Group, LLC position in JNJ

JOHNSON & JOHNSON · Health Care

Ullmann Wealth Partners Group, LLC reported holding 13,594 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$3.6M, representing 0.32% of its reported portfolio and ranking #38 among its reported holdings. Ullmann Wealth Partners Group, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)13.59K sh
Reported value held$3.60M
Portfolio Weight0.32%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Ullmann Wealth Partners Group, LLC's JNJ position evolved

Ullmann Wealth Partners Group, LLC first disclosed a stake in JNJ in Q3 2023 at 4,495 shares (US$700K). The position peaked in Q3 2026 at 13,594 shares, worth US$3.6M. Across 13 filings, Ullmann Wealth Partners Group, LLC increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 13,594 shares valued at US$3.6M — an increase of 827 shares quarter over quarter.. Notable position changes include a 30% increase in Q3 2024 (shares fell 11% over the following quarter), a 190% increase in Q1 2025 (shares fell 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.50K $700.17K New
Q4 2023 4.39K $688.32K Reduce
Q1 2024 4.98K $788.18K Add
Q2 2024 4.85K $708.51K Reduce
Q3 2024 6.29K $1.02M Add
Q4 2024 5.27K $762.55K Reduce
Q1 2025 15.31K $2.54M Add
Q2 2025 15.19K $2.32M Reduce
Q3 2025 12.48K $2.31M Reduce
Q4 2025 12.48K $2.36M Hold
Q1 2026 12.66K $3.10M Add
Q2 2026 12.77K $3.24M Add
Q3 2026 13.59K $3.60M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Ullmann Wealth Partners Group, LLC held JNJ?

Ullmann Wealth Partners Group, LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Ullmann Wealth Partners Group, LLC's current position in JNJ?

As of Q3 2026, Ullmann Wealth Partners Group, LLC holds 13.59K shares of JNJ (JOHNSON & JOHNSON), valued at $3.60M, representing 0.32% of its reported portfolio and ranking #38.

Has Ullmann Wealth Partners Group, LLC been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Ullmann Wealth Partners Group, LLC increased its position in JNJ. The position peaked in Q3 2026 at 13.59K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.